In vivo time-course of the angiogenic response induced by multiple myeloma plasma cells in the chick embryo chorioallantoic membrane

Journal of Anatomy

Volumn 203, Issue 3, 2003, Pages 323-328

  Ribatti, Domenico ^a   De Falco, Giuseppe ^a   Nico, Beatrice ^a   Ria, Roberto ^a   Crivellato, Enrico ^b   Vacca, Angelo ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Angiogenesis; Chorioallantoic membrane; Multiple myeloma; Plasma cells

Indexed keywords

ANGIOGENESIS; ARTICLE; CELL GROWTH; CELL SUSPENSION; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; HUMAN; HUMAN CELL; IMPLANTATION; IN VIVO STUDY; MITOSIS RATE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VASCULARIZATION;

ALLANTOIN; ANIMALS; CHICK EMBRYO; CHORION; COCULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; HUMANS; MULTIPLE MYELOMA; NEOVASCULARIZATION, PATHOLOGIC; PARAPROTEINEMIAS; PLASMA CELLS; TIME FACTORS;

GALLUS GALLUS;

EID: 0141815614     PISSN: 00218782     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-7580.2003.00220.x     Document Type: Article

References (25)

1. Ausprunk DH, Knighton DR, Folkman J (1974) Differentiation of the vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. Dev. Biol. 38, 237-247.
2. Billadeau D, Ahmann G, Greippe P, Van Ness B (1993) The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to malignant plasma cells. J. Exp. Med. 178, 1023-1033.
3. Dankbar B, Padro T, Leo R, Feldmann B, Kropff M, Mesters RM, et al. (2000) Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood 95, 2630-2636.
4. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1, 27-31.
5. Hideshima T, Chauhan D, Podar K, Schlossman RL, Richardson P, Anderson KC (2001) Novel therapies targeting the myeloma cells and its bone marrow microenvironment. Semin. Oncol. 28, 607-612.
6. Iwasaki T, Hamano T, Ogata A, Hashimoto N, Kitano M, Kakishita E (2002) Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma. Br. J. Haematol. 116, 796-802.
7. Jung YD, Mansfield PF, Akagi M, Takeda A, Liu W, Bucana CD, et al. (2002) Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model. Eur. J. Cancer 38, 1133-1140.
8. Kim ES, Serur A, Huang J, Manley CA, McCrudden KW, Frischer JS (2002) Potent VEGF blockade causes regression of coopeted vessels in a model of neuroblastoma. Proc. Natl Acad. Sci. USA 99, 11399-11404.
9. Knighton D, Ausprunk D, Tapper D, Folkman J (1977) Avascular and vascular phases of tumour growth in the chick embryo. Br. J. Cancer 35, 347-356.
10. Leene W, Duyzings MJM, Von Steeg G (1973) Lymphoid stem cell identification in the developing thymus and bursa of Fabricius of the chick. Z. Zellforsch. 136, 521-533.
11. Li CY, Shan S, Huang Q, Braun RD, Lanzen J, Hu K, et al. (2000) Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models. J. Natl Cancer Inst 92, 143-147.
12. Nico B, De Falco G, Vacca A, Roncali L, Ribatti D (2001) In vivo absence of synergism between fibroblast growth factor-2 and vascular endothelial growth factor. J. Hematother. Stem Cell Res. 10, 905-912.
13. Pepper MS, Mandriota SJ, Jeltsch M, Kumar M, Alitalo K (1998) Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity. J. Cell Physiol. 177, 439-452.
14. Ribatti D, Urbinati C, Nico B, Rusnati M, Roncali L, Presta M (1995) Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev. Biol. 170, 39-49.
15. Ribatti D, Gualandris A, Bastaki M, Vacca A, Iurlaro M, Roncali L, et al. (1997) A new model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane (CAM): the gelatin sponge/CAM assay. J. Vasc. Res. 34, 455-463.
16. Ribatti D, Gualandris A, Belleri M, Massardi L, Nico B, Rusnati M, et al. (1999) Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2. J. Pathol. 189, 590-599.
17. Ribatti D, Nico B, Morbidelli L, Donnini S, Ziche M, Vacca A, et al. (2001a) Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestrations and angiogenesis. J. Vasc. Res, 38, 389-397.
18. Ribatti D, Nico B, Vacca A, Roncali L, Burri PH, Djonov V (2001b) Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat. Rec. 264, 317-324.
19. Ribatti D, Cruz A, Nico B, Favier J, Vacca A, Corsi P, et al. (2002) In situ hybridization and immunogold localization of vascular endothelial growth factor receptor-2 in the pericytes of the chick embryo chorioallantoic membrane. Cytokine 17, 262-265.
20. Ribatti D, Vacca A, Dammacco F, English D (2003) Angiogenesis and anti-angiogenesis in haematological malignancies. J. Hematother. Stem Cell Res. 12, 11-22.
21. Sezer O, Jacob C, Eucker J, Niemoller K, Gatz F, Wernecke K, et al. (2001) Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma. Eur. J. Haematol. 66, 83-88.
22. Solomon JB (1971) Lymphocytopoiesis and ontogeny of defined immunity in birds. In Fetal and Neonatal Immunology New York, Frontiers of Biology, Monograph 20.
23. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, et al. (1994) Bone marrow angiogenesis and progression in multiple myeloma. Br. J. Haematol. 87, 503-508.
24. Vacca A, Ribatti D, Presta M, Minischetti M, Iurlaro M, Ria R, Albini A, Bussolino F, Dammacco F (1999) Bone marrow neo-vascularization, plasma cell angiogenic potential and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 93, 3064-3073.
25. Wedge SR, Ogilvie DJ, Dukes M, Kenderw J, Chester R, Jackson JA, et al. (2002) ZD 6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. Cancer Res. 62, 4645-4655.